Stem cell treatment for Alzheimer's disease

Area of Science:

• Neuroscience
• Regenerative Medicine
• Gerontology

Background:

• Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by memory loss and cognitive decline.
• Pathological hallmarks include beta-amyloid plaques, neurofibrillary tangles, and widespread neurodegeneration.
• Current treatments for AD primarily manage symptoms without addressing the disease's root causes.

Purpose of the Study:

• To review the current state of stem cell therapy research for Alzheimer's disease.
• To evaluate the potential of stem cells as a therapeutic strategy for AD.
• To highlight advancements and future directions in this field.

Main Methods:

• Literature review of preclinical and clinical studies on stem cell transplantation in AD models.
• Analysis of different stem cell types (e.g., mesenchymal stem cells, neural stem cells) and their mechanisms of action.
• Examination of studies investigating the effects of stem cells on AD pathology and cognitive function.

Main Results:

• Stem cell therapy has demonstrated potential in preclinical models to reduce amyloid burden and neuroinflammation.
• Transplanted stem cells may promote neurogenesis, synaptic plasticity, and neuronal survival.
• Evidence suggests stem cells can modulate the brain microenvironment to support neuronal health.

Conclusions:

• Stem cell therapy represents a promising, disease-modifying approach for Alzheimer's disease.
• Further research and clinical trials are necessary to optimize stem cell treatments for AD.
• Stem cell-based strategies hold potential for restoring cognitive function and halting AD progression.